Detailed price information for Texas Instruments (TXN-Q) from The Globe and Mail including charting and trades.

COHR y CBRS están aprovechando la demanda de IA, con sólidas perspectivas de crecimiento, ampliando las oportunidades de infraestructura y mejorando las estimaciones de ganancias.

TXN pairs broad chip-demand recovery, margin expansion and strong cash flow with a lower P/S multiple than fast-growing, loss-making CBRS.

Cerebras’s CEO and CTO sold nearly $200 million combined in stock right as GAAP gross margin collapsed and cash burn quadrupled in one quarter.

Key TakeawaysCerebras’s own core gross margin fell to 40. 6% in Q2 2026 from 46.

Cerebras has the buzz, the OpenAI partnership, and the fastest inference chips in the market. Innodata has 12 straight quarters of growth, record profits, and a broadening customer base.

IPOs get plenty of press, and rightly so. They are the lifeblood of the markets, bringing new opportunities and new capital into the stock ecosystem. But IPOs also bring hard choices and counter-intuitive results, and those deserve a closer look. To start with, long-term analysis shows that most IPOs will actually underperform compared to their first day on the market. That first day benefits from high valuations and even higher levels of investor enthusiasm – but enthusiasm will wear off, and b

Detailed price information for Alphabet Cl A (GOOGL-Q) from The Globe and Mail including charting and trades.

Detailed price information for Cerebras Systems Cl A (CBRS-Q) from The Globe and Mail including charting and trades.